Baxalta Incorporated;Baxalta GmbH;Immune Disease Institute, Inc.
发明人:
WAGNER, DENISA,CHAUHAN, ANIL KUMAR,SCHEIFLINGER, FRIEDRICH,PLAIMAUER, BARBARA
申请号：
PL06754405
公开号：
PL1902141T3
申请日:
2006.06.16
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
This invention relates to a pharmaceutical composition having thrombolytic activity comprising ADAMTS13, and to methods for treating or preventing a disorder associated with the formation and/or the presence of one or more thrombus and to methods of disintegrating one or more thrombus in a patient in need thereof. Furthermore, the invention relates to the use of a pharmaceutically effective amount of ADAMTS13 for the preparation of a pharmaceutical composition for treating or preventing a disorder associated with the formation or the presence of one or more thrombus and for disintegrating one or more thrombus in a patient in need thereof.
